Avtar Dhillon, MD
Avtar is a life sciences entrepreneur with more than 20 years experience building public companies through mergers and acquisitions, leading innovation in scientific, engineering and farming enterprises, securing government grants and NGO funding (more than $75 million U.S. to date), and building dominant IP portfolios through partnering. During his tenure as President and CEO at Inovio (NASDAQ: INO), Avtar led the turnaround of the company through restructuring and acquisitions. Under his leadership, Inovio completed financing totaling over $250 million and several licensing deals with global pharma leaders Merck, Wyeth (now Pfizer) and Roche. Before joining Inovio he was Vice President of MDS Capital Corp. (now Lumira Capital Corp.), one of North American’s leading healthcare venture capital organizations.
Avtar practiced family medicine for over 12 years. He has a BSc (Honours) in Human Physiology and an MD from the University of British Columbia.